Immunomic Therapeutics scores $61.3m
Immunomic Therapeutics Inc, a biotechnology company focused on nucleic acid immunotherapy platforms, has raised $61.3 million in financing
Immunomic Therapeutics Inc, a biotechnology company focused on nucleic acid immunotherapy platforms, has raised $61.3 million in financing
Copyright PEI Media
Not for publication, email or dissemination